<VariationArchive VariationID="2582305" VariationName="NM_005120.3(MED12):c.4483_4490del (p.Gln1495fs)" VariationType="Deletion" Accession="VCV002582305" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2023-10-07" MostRecentSubmission="2024-05-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2749878" VariationID="2582305">
      <GeneList>
        <Gene Symbol="MED12" FullName="mediator complex subunit 12" GeneID="9968" HGNC_ID="HGNC:11957" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="71118596" stop="71142450" display_start="71118596" display_stop="71142450" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="70338405" stop="70362303" display_start="70338405" display_stop="70362303" Strand="+" />
          </Location>
          <OMIM>300188</OMIM>
          <Haploinsufficiency last_evaluated="2018-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MED12">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MED12">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005120.3(MED12):c.4483_4490del (p.Gln1495fs)</Name>
      <CanonicalSPDI>NC_000023.11:71132910:ACAACGCGA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="71132911" stop="71132918" display_start="71132911" display_stop="71132918" variantLength="8" positionVCF="71132910" referenceAlleleVCF="AACAACGCG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="70352761" stop="70352768" display_start="70352761" display_stop="70352768" variantLength="8" positionVCF="70352760" referenceAlleleVCF="AACAACGCG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>Q1495fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.70352762_70352769del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.70352762_70352769del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.71132912_71132919del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.71132912_71132919del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012808.1" sequenceAccession="NG_012808" sequenceVersion="1" change="g.19357_19364del">
            <Expression>NG_012808.1:g.19357_19364del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005120.3" sequenceAccession="NM_005120" sequenceVersion="3" change="c.4483_4490del" MANESelect="true">
            <Expression>NM_005120.3:c.4483_4490del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005111.2" sequenceAccession="NP_005111" sequenceVersion="2" change="p.Gln1495fs">
            <Expression>NP_005111.2:p.Gln1495fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005120.3(MED12):c.4483_4490del (p.Gln1495fs) AND Cholestasis-pigmentary retinopathy-cleft palate syndrome" Accession="RCV003333271" Version="1">
        <ClassifiedConditionList TraitSetID="70221">
          <ClassifiedCondition DB="MedGen" ID="C0795969">Cholestasis-pigmentary retinopathy-cleft palate syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005120.3(MED12):c.4483_4490del (p.Gln1495fs) AND Nonspecific Intellectual Disability" Accession="RCV004527456" Version="1">
        <ClassifiedConditionList TraitSetID="97246">
          <ClassifiedCondition>Nonspecific Intellectual Disability</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-04-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-04-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-10-07" MostRecentSubmission="2024-05-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="70221" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6910" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hardikar syndrome</ElementValue>
                <XRef ID="Hardikar+Syndrome/3239" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cholestasis-pigmentary retinopathy-cleft palate syndrome</ElementValue>
                <XRef ID="MONDO:0012997" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HDKR</ElementValue>
                <XRef Type="MIM" ID="301068" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9280" />
                <XRef ID="9280" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">MED12-related disorders include the phenotypes of FG syndrome type 1 (FGS1), Lujan syndrome (LS), X-linked Ohdo syndrome (XLOS), Hardikar syndrome (HS), and nonspecific intellectual disability (NSID). FGS1 and LS share the clinical findings of cognitive impairment, hypotonia, and abnormalities of the corpus callosum. FGS1 is further characterized by absolute or relative macrocephaly, tall forehead, downslanted palpebral fissures, small and simple ears, constipation and/or anal anomalies, broad thumbs and halluces, and characteristic behavior. LS is further characterized by large head, tall thin body habitus, long thin face, prominent nasal bridge, high narrow palate, and short philtrum. Carrier females in families with FGS1 and LS are typically unaffected. XLOS is characterized by intellectual disability, blepharophimosis, and facial coarsening. HS has been described in females with cleft lip and/or cleft palate, biliary and liver anomalies, intestinal malrotation, pigmentary retinopathy, and coarctation of the aorta. Developmental and cognitive concerns have not been reported in females with HS. Pathogenic variants in MED12 have been reported in an increasing number of males and females with NSID, with affected individuals often having clinical features identified in other MED12-related disorders.</Attribute>
                <XRef ID="NBK1676" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301719</ID>
                <ID Source="BookShelf">NBK1676</ID>
              </Citation>
              <XRef ID="1415" DB="Orphanet" />
              <XRef ID="C0795969" DB="MedGen" />
              <XRef ID="C535632" DB="MeSH" />
              <XRef ID="MONDO:0012997" DB="MONDO" />
              <XRef Type="MIM" ID="301068" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="97246" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="76308" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nonspecific Intellectual Disability</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7562140" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="49316|OMIM:301068" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004040646" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005120.3:c.4483_4490del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="301068" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858665</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9755942" SubmissionDate="2024-04-26" DateLastUpdated="2024-05-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="MED12 S14|Nonspecific Intellectual Disability" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005038923" DateUpdated="2024-05-07" DateCreated="2024-05-07" Type="SCV" Version="1" SubmitterName="Daryl Scott Lab, Baylor College of Medicine" OrgID="505993" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MED12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005120.3:c.4483_4490del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nonspecific Intellectual Disability</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14405013</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7562140" TraitType="Disease" MappingType="XRef" MappingValue="301068" MappingRef="OMIM">
        <MedGen CUI="C0795969" Name="Cholestasis-pigmentary retinopathy-cleft palate syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9755942" TraitType="Disease" MappingType="Name" MappingValue="Nonspecific Intellectual Disability" MappingRef="Preferred">
        <MedGen CUI="None" Name="Nonspecific Intellectual Disability" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

